The UPS is highly regulated at multiple levels. An emerging concept is that the specificity-conferring components of the UPS, the E3s, as well as other components of the system, can be regulated by ubiquitylation (also known as ubiquitination, the term coined by the discover ers of this modification as related to proteo lysis 1 ) and subsequent degradation, mediated either by themselves (a process known as self-or auto-ubiquitylation) or by heterologous ligases. However, there are also clear examples in which self-ubiquitylation of E3s serves not as a degradation signal but rather to alter the function of these proteins. This Review focuses on examples of both of these concepts, as well as the regulated degradation of ubiquitin and the proteasome.
Degradation of ubiquitin
The ability of the UPS to carry out its numerous functions depends on the availability of free ubiquitin. Cellular ubiquitin levels are regulated by synthesis and degradation, as well as by rates of protein ubiquitylation and deubiquitylation. Although ubiquitin levels vary among tissues, with developmental stage and with differentiation and metabolic activity (for example, under stress, when proteolysis rates increase, free ubiquitin levels fall 2, 3 ), the ratio of free ubiquitin to proteinconjugate d ubiquitin is approximately 1/1 (REFS 4, 5) . As ubiquitin is physically stable and remains properly folded and active after exposure to extreme conditions 6, 7 , it was thought to be resistant to catabolism. However, ubiquitin has a finite half-life, and its degradation and steady state level reflects overall protein turnover 4, 8, 9 . Ubiquitin can be also depleted when it is not properly removed and recycled from targeted degraded substrates (REF. 10 and below). Ubiquitin can be degraded by the 26 proteasome in three ways: as a monomer; along with its conjugated substrate through a 'piggyback' mechanism; and as a fusion protein with a short carboxy-terminal tail (or as part of an isopeptide conjugate with a short peptide 2, 11, 12 ) (N.S. and A.C., unpublished observations) (FIG. 2A) .
Degradation of monomeric ubiquitin. Ubiquitin is relatively stable and has a half-life of ~10 hours 2, 4, 8, 9, 11 . Its degradation requires ATP and is mostly proteasomemediated 2, 4, 9 . As monomeric ubiquitin binds to the proteasome but does not have a long enough tail to allow it to be 'pulled' into the 20S catalytic particle (CP), it itself has to be ubiquitylated in order to be degraded. This provides the tagged ubiquitin with sufficient freedom of movement to allow for entry into the proteasomal CP. Ubiquitylation is catalysed by a specific E2, E2-25 kDa (E2-25K; also known as UBE2K), which catalyses E3-independent addition of proteasome-targeting Lys48-linked chains ('canonical' ubiquitin chains) to monomeric ubiquitin 13 , and by the HECT domain-containing E3 thyroid receptorinteracting protein 12 (TRIP12), which can also ubiquitylate ubiquitin and target it for degradation 14 . The relativ e importance of these two modes of ubiquitylation of ubiquitin (E3-independent and E3-dependent) to the degradation of monomeric ubiquitin, and the overall contribution of the degradation of monomeric ubiquitin to its catabolis m are not known.
Intriguingly, although ubiquitin is ubiquitylated to become a target substrate, it has also been shown that ubiquitin can exist as 'unanchored' free polyubiquitin chains. Although the physiological role (or roles) of the low steady-state levels of these chains remains elusive, several functions have been attributed to them, including being involved in nuclear factor-κB (NF-κB) signalling 15 and serving as an easily accessible source of monomeric ubiquitin when disassembled by DUBs 16 .
Degradation of ubiquitin with its target substrate.
Ubiquitin can be degraded along with its target substrate in a piggyback mechanism. The accelerated degradation of cellular proteins that occurs with various forms of cell ular stress, probably owing to misfolding or other forms of protein damage, is accompanied by accelerated degradation of ubiquitin 2, 4, 9 . Also, deletion of proteasomeassociated DUBs, such as yeast ubiquitin-specificprocessing protease 6 (Ubp6; USP14 in mammals) and mammalian ubiquitin C-terminal hydrolase 37 (UCH37; also known as UCHL5) -which presumably function with the proteasomal subunit RPN11 to remove ubiquitin chains before entry of the substrate into the 20S CPaccelerates substrate degradation and results in depletion of ubiquitin 10, [17] [18] [19] [20] . Interestingly, depletion of ubiquitin results in transcriptional upregulation of Ubp6 (REF. 21 ), suggesting an autoregulatory feedback loop. Also, Ubp6 acts non-catalytically to slow protein degradation by decreasing the flux of proteins through the proteasome, possibly to allow efficient removal and recycling of ubiquitin from the chains tagged to the substrate before its entry into the 20S CP to be degraded 32 . Using a reconstituted cell-free system, it has been shown that the addition of bona fide substrates of the UPS enhances proteasomedependent degradation of ubiquitin, when preceded by conjugation of the degraded ubiquitin to the substrates. This finding provides direct evidence in support of the , where, in most cases, a stable isopeptide bond is formed between the activated carboxy-terminal Gly 77 of ubiquitin and an εNH 2 group of an internal Lys residue in the substrate is formed. Additional ubiquitin moieties are then added to generate a polyubiquitin chain. d | Alternatively, activated ubiquitin can be transferred directly from E2 to an internal Lys residue in a substrate that is bound to a RING finger domain-containing ubiquitin ligase. Polyubiquitin chains linked through Lys48 of ubiquitin are characteristically associated with proteasomal degradation. However, linkages through several of the other seven Lys residues in ubiquitin have recently been shown to also target for proteasomal degradation [120] [121] [122] [123] . In some cases, ubiquitin is conjugated to the αNH 2 group of the target substrate (reviewed in REF. 25) , and there are a few examples of conjugation to internal substrate Thr, Ser or Cys residues [123] [124] [125] [126] [127] [128] [129] . Certain substrates are recognized by several ligases that act under different conditions, either sequentially or in parallel, recognizing different motifs in the substrate. Such a mechanism may be necessary to allow recognition and degradation of different domains in the substrate. e | Degradation of the ubiquitin-conjugate d substrate to short peptides by the 26S proteasome. The binding of ubiquitylated proteins to the proteasome can be direct, or mediated or enhanced by shuttling proteins. f | Most of the ubiquitin chain is disassembled by deubiquitylating enzymes (DUBs) and the rest is probably degraded along with the substrate. Select substrates are processed rather than completely degraded by the 26S proteasome. This is due, at least in part, to unstructured sequences (for example, Gly-Ala repeats) that may inhibit entry into the proteasome, although additional mechanisms may be involved. piggyback mechanism 11 . It is assumed that part of the chain, probably the proximal part, which is closer to the substrate, is degraded with the substrate, whereas the other moieties, probably the ones that are more distal to the substrate, are 'rescued' and recycled.
An interesting question is whether this piggyback mode of degradation serves a mechanistic role and is a consequence of the need to degrade the substrate, or whether it is a by-product of the proteolytic process. It is possible that part of the ubiquitin chain must always be present on the substrate to secure its binding to the proteasome, and that its premature removal can result in detachment of the substrate before complete entry into the proteasome. It has been reported recently that the initial, relatively weak and reversible association of the conjugated substrate with the proteasome, which is mediated by the ubiquitin chain, is followed by a tighter association between the substrate and the proteasome, which requires ATP hydrolysis and a loosely folded domain on the protein but appears to be ubiquitin-independent 23 . Thus, according to this study, it is possible that mechanistically it is not necessary to degrade part of the ubiquitin chain along with the tagged substrate and that it can be completely rescued and/or detached while the substrate, which is now bound in a tighter association that does not require ubiquitin, is degraded. However, as experimenta l evidence suggests that part of the chain is degraded along with the substrate 11 , it is possible that the movement of the substrate into the CP can be more rapid than the hydrolytic activity of proteasomal DUBs, and therefore part of the chain cannot be rescued. Alternatively, the chain is required throughout most of the proteolytic process, cannot be released earlier and is therefore partially degraded. Additional detailed mechanistic studies will be necessary to dissect the role of the polyubiquiti n chains once the substrate has reached the interior of the CP and degradation has been initiated. In addition to DUBs, other proteins have recently been found to be involved in regulating ubiquitin homeostasis. These include regulator of free ubiquitin chains 1 (Rfu1), which inhibits the DUB Doa4 and probably controls the equilibrium between monomeric ubiquitin and free ubiquitin chains 16 . Degradation of ubiquitin fused or conjugated to short peptides. Several studies have demonstrated that ubiquitin with a C-terminal extension that is longer than 20 amino acids is degraded efficiently by the proteasome Figure 2 | Modes of degradation of ubiquitin and ubiquitin-protein ligases. A | Ubiquitin (Ub) can be degraded in three ways (the monomer to be degraded is indicated in light blue). Aa | It can be degraded as a monomer following its polyubiquitylation. The process is probably slow, as the ubiquitin substrate molecule is short and lacks the unstructured tail that appears to be an important structural characteristic necessary for efficient proteasomal degradation. Ab | Ubiquitin is degraded with its conjugated substrate. The proximal part of the polyubiquitin chain is probably degraded along with the substrate, whereas the distal part is removed by deubiquitylating enzymes, resulting in the release of free and reusable ubiquitin. Ac | Ubiquitin with a carboxy-terminal unstructured tail that is longer than 20 amino acid residues is degraded efficiently by the proteasome. B | Modes of degradation of ubiquitin-protein ligases (E3s) by ubiquitylation. Ba | Degradation of a ligase mediated by self-ubiquitylation. Both RING domain-containing and HECT domain-containing ligases can catalyse self-ubiquitylation to generate polyubiquitin chains that target the proteins for proteasomal degradation. Selfubiquitylation is shown as occurring in cis (that is, on the same molecule). However, as many E3s dimerize and may form higher order oligomers, ubiquitylation can also occur in trans, as discussed for yeast HMG-CoA reductase degradation protein 1 (Hrd1) in the main text. Bb | Ubiquitylation of a ligase by a heterologous ligase. Although in the described cases of this mode of ubiquitylation the reaction is unidirectional (see main text and FIGS 3,4), bidirectional ubiquitylation is also a possibility. Bc | Hierarchical ubiquitylation of ligases. In this hypothetical scheme, one ligase targets several substrate ligases in a hierarchical manner. As has been described for several substrates of the ubiquitin system, one ligase substrate can be targeted by more than a single ligase (middle ligase in the lower row and left ligase in the middle row). The ligase at the top is targeted by self-ubiquitylatio n or by one of the ligases that it directly or indirectly regulates. Solid arrows represent the predominant interactions, dashed arrows represent interactions that may also occur. E2, ubiquitin-conjugating enzyme. and that the degradation is not dependent on further ubiquitylation 2, 11, 12 ; however, ubiquitin with a shorter extension is stable and not degraded. Similar findings have been shown using ubiquitin that is synthetically conjugated with an isopeptide bond to short peptides (N.S. and A.C., unpublished observations) 24 . The in vivo sources of these ubiquitin-bound peptides (which were synthetically generated as model substrates in the studies described) are unknown, and they have not been isolated from cells. They could be intermediates of proteasomal degradation of larger cellular substrates, in which the ubiquitin moiety is bound either to an internal Lys residue of the substrate via an isopeptide bond or to its amino-terminal residue via a linear peptide bond 25 . Such ubiquitin conjugates can also be products of the ubiquitylation of peptides that might either have their own cellular function or be derived from larger proteins via different processing or destructive processes. Thus, to be removed, these peptides must undergo ubiquitylation to be targeted for proteasomal degradation. Although short peptides to which ubiquitin is bound either linearly or via an isopeptide bond have not been isolated and/or characterized in mammalian cells, evidence for their existence was found in yeast cells lacking Doa4 (REF. 26 ), which is a DUB implicated in endocytosis and vacuolar degradation 27 . An important implication of the efficient degradation of C-terminally tailed ubiquitin is that it defines the two minimal requirements for proteasomal recognition and degradation of intact substrates: a proteasomalbinding domain (ubiquitin) and an unstructured tail that is long enough (>20 residues) to allow the molecule to physically extend through the 19S regulatory particle (RP) into the CP 28 (FIG. 2Ac) . The requirement for an unstructured tail has been demonstrated with several model substrates. Whether this concept holds true in cells for polyubiquitylated and normally folded cellular proteins awaits determination. For such proteins, an important problem is determining the mechanism (or mechanisms) that unfolds a segment to allow entry of the substrate into the CP. It is possible that ubiquitylation destabilizes the protein and results in an unfolded segment. Alternatively, a chaperone-assisted mechanism could be involved. Also, there could be a role for the ATPases at the base of the 19S subunit in this process.
A naturally occurring pathological variant of ubiquitin is UBB +1 , which is ubiquitin that has been extended by a 19 residue C-terminal tail. UBB +1 is synthesized owing to a dinucleotide deletion during transcription and is implicated in the pathogenesis of an early onset form of Alzheimer's disease and other neurological and conformational disorders 29 . UBB +1 cannot be activated by E1 and therefore is not conjugated to other proteins, but it has been shown to inhibit proteasome function 11, 30 . Its toxicity is probably due to two mechanisms: it binds to the proteasome but it is resistant to degradation owing to its short 19 residue tail; and it can be ubiquitylated, which creates UBB +1 -anchored ubiquitin chains that are resistant to DUBs. The high affinity of the ubiquitylated UBB +1 with its non-degradable ubiquitin chains for the 26 proteasome makes it an efficient inhibitor of the proteasome 11, 30 . Experimental extension of the tail of UBB +1 by a single residue renders the protein susceptible to proteasomal degradation without further ubiquitylation 11 . The finding that tailed ubiquitin is degraded efficiently by the proteasome raises the possibility that polyubiquitylation is required to increase the affinity of large substrates to the proteasome to render proteolysis more efficient, but for short substrates a single moiety or short oligoubiquitin chains may be sufficient when an adequate unstructured domain is also present.
Regulating UPS enzymes by ubiquitylation. Specificity in ubiquitylation is determined largely by ubiquitin-protein ligases, of which there are over 600 in humans. These each function together with subsets of E2s. Given the exquisite regulation of ubiquitylation and its ability to alter both the fate and function of substrates, it is not surprising that E3s might be regulated by targeting themselves for ubiquitylation (regulatory self-ubiquitylatio n) (FIG. 2B) . Self-ubiquitylation is a general property of E3s in vitro 31 and is often used to confirm that proteins are active ligases and to assess functionally significant inter actions with specific E2s. There are now a number of cases of documented selfubiquitylation in cells (see TABLE 1 for examples).
The canonical result of ligase self-ubiquitylation is auto-regulation or targeting for self-destruction, with the main role of the ligase in most cases being to target heterologous substrates. The complexity of E3 regulation is further accentuated by an increasing number of examples in which an E3 that may or may not self-ubiquitylate is subject to ubiquitylation by another E3 (regulation by heterologous E3s; FIG. 2B), with self-ubiquitylation and heterologous ubiquitylation of the same ligase signalling for either the same or different outcomes. When different outcomes occur, self-ubiquitylation has been shown to serve regulatory, non-proteolytic functions, whereas the heterologous modification targets the E3 for degradation (discussed below; TABLE 1).
The complex relationship between the multisubunit APC/C (anaphase-promoting complex/cyclosome) and the SCF (Skp1-cullin-F box) families of E3s throughout the cell cycle provides the ultimate example of both self and heterologous regulation of E3s by ubiquitylation and proteasomal degradation, in this case to ensure regulated cell proliferation and genomic integrity
. Similarly, DUBs and E2s are also subject to ubiquitylation, with evidence, at least in one case, suggesting E3-independent self-ubiquitylation of an E2 (REF. 32) (BOX 1; TABLE 1). There are also examples of enzymes involved in UBL modification of proteins that are targets for ubiquitylation or vice versa. The most extensively studied UBLmediated modification of E3s, and the one with the widest range of known consequences, is the activating modification of the cullin subunits of the cullin-RING ligase (CRL) superfamily of E3s by the UBL NEDD8 (TABLE 1) . Moreover, an increasing number of proteins that contain ubiquitin receptor domains (reviewed in REF. 33 ) are also ubiquitylatio n substrates. Self-ubiquitylation in regulating the tumour suppressor p53. Regulatory self-ubiquitylation (FIG. 2B) is illustrated by considering the control of p53. This protein, which is known as 'the guardian of the genome' , is normally maintained at low levels (largely owing to the UPS) to allow normal cell growth and proliferation; however, under conditions of genotoxic stress its degradation is suppressed through a variety of mechanisms, leading to upregulation of genes that result in either growth arrest or apoptosis. In this regard, mutation or loss of TP53 expression is a common feature of many malignancies (reviewed in REF. 34 ). Although a number of E3s have been suggested to be involved in p53 ubiquitylation, MDM2 (also known as HDM2 in humans) is of unquestionable importance. MDM2 is a RING finger E3 that can form homo dimers through its RING finger and binds directly to p53, which exists primarily as a homotetramer. MDM2 targets multi ple C-terminal Lys residues of p53 for ubiquitylation (reviewed in REF. 35 ). MDM2 undergoes self-ubiquitylation in vitro 36, 37 and targets itself and p53 for RING f inger-dependent degradation in vivo 36 . The closely related protein MDMX (also known as MDM4, and as HDMX and HDM4 in humans), has little propensity to form homodimers but rather forms heterodimers with MDM2 through an extended surface centred on their RING fingers 38 . Although the MDMX RING finger lacks ligase activity, the heterodimer is an active E3 that is generally believed to be the predominant cellular ligase for p53 (REF. 39 ) (reviewed in REFS 34, 35) . MDMX can also directly bind p53 in a fashion similar to MDM2. Notably, MDMX lacks the nuclear export and nuclear and nucleolar localization signals that are characteristic of MDM2. MDMX can also be ubiquitylated and targeted for degradation by MDM2, presumably in the context of MDM2-MDMX heterodimers (reviewed in REFS 34, 35) . Consistent with this, expression of MDMX decreases ubiquitylation and degradation of MDM2, presumably by competing with MDM2 in the formation of dimers and thereby decreasing the capacity of one MDM2 molecule to ubiquitylate another. There is evidence that the MDM2/MDMX ratio has important roles in p53 ubiquitylation and degradation. MDMX enhances the activity of MDM2 towards p53 (REFS 40, 41) . However, MDMX has also been associated with the stabilization of p53 (REF. 42 ). This role is attributed to the attenuation of nuclear export of p53 by MDM2, which is believed to lead to the degradation of p53 in the cytoplasm. Thus, although it is critical for issues of p53 stability, degradation and localization that MDM2 and MDMX be maintained in a proper stoichiometric relationship, exactly how the relationship affects p53 function remains an area of intense investigation. An additional level of complexity in the relationship between p53, MDM2 and MDMX is illustrated by the function of the DUB ubiquitin-specific protease 7 (USP7; also known as HAUSP). This DUB (which was first shown to deubiquitylate p53) has as its primary activity under non-stressed conditions the deubiquitylation and stabilization of MDM2 and MDMX 43, 44 . However, in response to genotoxic stress, phosphorylation of MDM2 and MDMX leads to decreased USP7 association and to their destabilization, which further contributes to p53 activation by ataxia-telangiectasi a mutated (ATM) and downstream kinases 45, 46 .
Heterologous and self-ubiquitylation in regulating transmembrane signalling. Ubiquitylation has important roles in the regulation of transporters, receptors and associated components of signalling pathways at the plasma , unidentified SCF E3 ligase; SIAH, seven in absentia homologue 1; SKP2, S phase kinase-associated protein 2; SUMO, small ubiquitin-like modifier; TNFR2, tumour necrosis factor receptor 2; TRAF2, TNFR-associated factor 2; UBA, ubiquitin-associated; Ubc, ubiquitin-conjugating enzyme; UBL, ubiquitin-like protein; UCHL1, ubiquitin C-terminal hydrolase isozyme L1; UIM, ubiquitin-interacting motif; USP, ubiquitin-specific protease; XIAP, X chromosome-linked IAP. The NEDD4 family (the yeast orthologue of which is Rsp5) has nine members; prominent among these are the functionally distinct NEDD4-1 (sometimes just referred to as NEDD4) and NEDD4-2 (also known as NEDD4L) isoforms and ITCH. NEDD4 family members are generally characterized by an N-terminal conserved region 2 (C2) domain, 2 to 4 WW domains and a C-terminal conserved HECT ubiquitin ligase domain. C2 domains serve as sites for membrane localization by binding to phospholipids and to proteins. Most known substrate interactions occur through the Trp-based WW domains. Like Src homology 3 (SH3) domains, these generally recognize Pro-containing PY motifs (reviewed in REF. 48 ). However, these labels belie the combinatorial complexity between various WW domains and PY motifs 49 . The CBL family of E3 ligases was characterized consequent to the discovery of v-CBL as the product of the transforming gene of the Cas NS-1 murine leukaemia virus (reviewed in REF. 50 ). Mutations in CBL proteins (including v-CBL) that result in the loss of their RING finger-dependent E3 activity can function as dominant negatives, resulting in sustained signalling. Such mutations can therefore be oncogenic, as evidenced by the association between such CBL mutations and myeloid leukaemias (reviewed in REF. 51 ). There are three mammalian CBL proteins: CBL (also known as c-CBL), CBL-B and CBL-C (also known as CBL-3). Each has an N-terminal Tyr kinase-binding (TKB) domain, a conserved RING finge r and a Pro-rich region. Both the TKB domain and the Prorich region mediate numerous protein interactions 52 . CBL proteins are recruited through their TKB domains to active signalling complexes, most notably transmembrane receptor Tyr kinases (RTKs) and receptors linked to Tyr kinases. They target these receptors and associated components for ubiquitylation, leading to their lysosomal targeting and degradation. Thus, CBL proteins serve as potential tumour suppressors by attenuating receptor-mediated mitogenic signalling (reviewed in REF. 50 ). As part of this process, CBL proteins undergo self-ubiquitylation, leading to their degradation and thereby regulating their own levels (FIG. 3a) . The degradation of CBL proteins is dependent on their interactions with RTKs (and vice versa) and on CBL E3 activity. Degradation of activated receptors, as well as of associated signalling molecules and recruited CBL, is blocked by either lysosome or proteasome inhibitors, suggesting coordinated degradation of the signalling complex 53 . Whether this means that CBL degradation occurs in lysosomes, proteasomes or both is unclear.
Another mechanism by which CBL proteins can be targeted for degradation is by interacting with the NEDD4 family of HECT domain E3s, mediated through interactions between the Pro-containing regions of CBL proteins and the WW domains of NEDD4 family members. NEDD4-1 and ITCH interact with and target all three CBL proteins for ubiquitylation and degradation (FIG. 3a) . This CBL ubiquitylation leads to proteasomal degradation and is dependent on an intact HECT domain but independent of a functional RING finger 54 . Thus, CBL proteins are bona fide NEDD4 and ITCH family substrates. The consequences of this interaction include delayed downregulation of activated epidermal growth Box 1 | Cross-regulation of ubiquitin ligase complexes during the cell cycle
The APC/C (anaphase-promoting complex/cyclosome) is central to cell cycle regulation. The 13-subunit APC/C complex includes either of two substrate recognition elements with distinct specificities, CDC20 or CDC20 homologue 1 (CDH1). APC/ C CDC20 and APC/ C CDH1 are tightly regulated to ensure appropriate cell cycle-dependent degradation of substrates (reviewed in REF. 102 ). Regulation of cullin-containing SKP1-cullin-F box (SCF) ubiquitin-protein ligase (E3) family acivity is also essential for cell cycle progression. In particular, the levels of S phase kinase-associated protein 2 (SKP2) and activity towards specific substrates of β-transducin repeat-containing protein (β-TrCP) SCF E3s are regulated during the cell cycle. APC/C and SCF E3s are cross-regulated to ensure correct cell cycle progression (see the figure, APC/C components are shown with a pink background and SCF components with a blue background). In late G2 and early M phase, the APC/C is inactivated by the spindle assembly checkpoint (SAC; also known as the mitotic checkpoint complex) pending alignment of chromosomes along the mitotic spindle (step 1). Once this occurs, APC/C CDC20 is activated and targets substrates that are essential for the completion of mitosis (reviewed in REF. 102) (step 2). After mitosis, APC/ C CDC20 is inactivated (reviewed in REF. 103 ) through the replacement of CDC20 with CDH1, which, when dephosphorylated, can associate with the APC/C (step 3). This dephosphorylation is an indirect effect of APC/C CDC20 , which targets cyclin A for degradation, thereby inactivating cyclin-dependent kinase 1 (CDK1; not shown), which is critical for CDH1 phosphorylation (reviewed in REF. 102 ). APC/C CDH1 further inactivates APC/C CDC20 by targeting CDC20 for polyubiquitylation (Ub n ) and degradation beginning in telophase and continuing into G1 (step 4). To prevent premature G1 to S progression, the cyclin E-CDK2 complex is kept inactive by the G1-S CDK inhibitor p27 KIP . A key E3 for p27 KIP is SCF SKP2 (REFS 104-106). To maintain p27 (also known as KIP1) levels, SKP2 is targeted by APC/C CDH1 during G1 (REFS 107,108) (step 5). As G1 ends, APC/C CDH1 is inactivated through multiple mechanisms, including targeting of the ubiquitinconjugatin g enzyme (E2) UBCH10 (also known as UBE2C) 109 for degradation by APC/C CDH1 (step 6), and ubiquitylation of CDH1 by both APC/C CDH1 (REF. 110 ) and an unidentified SCF E3 ligase 111 (SCF X ) (steps 7, 8) . This allows accumulation of SCF SKP2 and p27 degradation, which facilitates transition into S phase (step 9). Synthesis of the APC/C pseudosubstrate early mitotic inhibitor 1 (EMI1; also known as FBXO5) initiates in late G1. EMI1 binds APC/ C CDH1 during late G1 and S, contributing to APC/C CDH1 inactivation [112] [113] [114] (reviewed in REF. 115) (step 10). In some cells, EMI1 similarly inhibits APC/C CDC20 (step 11). In early M, EMI1 is phosphorylated by CDK and Polo-like kinase 1 (PLK1), leading to its targeting for degradation by SCF β-TrCP (REFS 116-119) (step 12). Until prometaphase, the SAC is the primary means by which APC/C CDC20 is held in check (step 1). Step 2: the receptors, together with other components of the signalling complex, are endocytosed and phosphorylated; CBL proteins are recruited. CBL proteins mediate the ubiquitylation of receptors and associated proteins as well as self-ubiquitylation, resulting in the targeting of receptors for lysosomal degradation and the destruction of CBL molecules -whether this degradation is lysosomal or proteasomal has not been determined with certainty.
Step 3: the net result is decreased recycling of receptors to the cell surface and the downregulation of signalling.
Step 4 (right panel): NEDD4 family members (including NEDD4-1 and ITCH) target CBL proteins for proteasomal degradation, lowering the cellular levels of these ubiquitin-protein ligases (E3s).
Step 5: as a result, the ubiquitylation of activated receptor Tyr kinase complexes is decreased. This results in attenuation of receptor downregulation, leading to increased mitogenic signalling. b | Regulation of gp78 and effects on substrates. gp78 is a polytopic RING finger E3 found in the endoplasmic reticulum (ER) that mediates self-ubiquitylation using the ubiquitinconjugatin g enzyme (E2) UBE2G2 (left branch). This activity requires an intact gp78 RING finger, the ubiquitin-binding coupling of ubiquitin conjugation to ER degradation (CUE) domain (the function of which in this process is not yet clear) and a highly specific binding site for UBE2G2 that is distinct from the RING finger, the UBE2G2-binding region (G2BR) 66 . In addition, gp78 can be targeted for ubiquitylation by a heterologous RING finger E3, HMG-CoA reductase degradation protein 1 (HRD1; also known as synoviolin) (right branch). This targeting is dependent on the HRD1 RING finger but is independent of the gp78 RING finger. Both of these modes of degradation lead to proteasomal degradation of gp78 and, consequently, to increased levels of gp78 substrates, including insulin-induced gene 1 (INSIG1) and KAI1, a regulator of cholesterol metabolism and a metastasis suppressor, respectively. C, carboxyl terminus; GRB2, growth factor receptor-bound 2; N, amino terminus; SHC, Src homology 2 domain-containing protein; Ub, ubiquitin.
Helper T cells
T cells that function as inducers of the effector cells for humoral and cell-mediated immunity. These cells recognize and bind antigens.
Unfolded protein response (UPR).
A cellular response that is triggered by the accumulation of misfolded proteins in the endoplasmic reticulum (ER) and that results in the transcriptional upregulation of ER chaperones and degradative enzymes and a general inhibition of protein synthesis.
factor receptor (EGFR) and, consequently, sustained mitogen-activated protein kinase (MAPK) activation 54 . The relationship between the two classes of E3s is asymmetrical; there is little evidence that NEDD4 famil y members are targeted by CBL proteins. Such asymmetry is a recurrent theme in many of the examples in subsequen t sections.
The relationship between these ligase families has been confirmed in helper T cells from Nedd4 -/-embryos. These T cells have decreased activation, as assessed by interleukin-2 (IL-2) production and increased CBL-B levels, which inhibits signalling downstream of the T cell antigen receptor (TCR). In addition, small interfering RNA (siRNA) knockdown of CBL-B increases IL-2 levels 55 . These observations are in accord with evidence implicating CBL-B as a negative regulator of TCR signalling (reviewed in REFS 50, 56) .
Some insights into the physical and functional relationship between members of these families come from studies on ITCH and CBL. ITCH is a substrate for JUN N-terminal kinase (JNK) 57 , which is activated by various stimuli, including signalling through EGFR. ITCH phosphorylation results in a conformational change that activates the protein, as determined by enhanced selfubiquitylation 57 . This phosphorylation also facilitates binding of CBL and other substrates 58 . This suggests a positive feedback loop in which EGFR signalling can be prolonged by downregulation of CBL by activated ITCH. A further level of regulation arises from the JNK-dependent binding of WW domains of ITCH to the DUB USP9X (also known as FAM; the mammalian counterpart of Drosophila melanogaster Fat facets). At a minimum, this interaction decreases the ubiquitylation of ITCH and therefore increases its availability 58, 59 . Whether this DUB diminishes ITCH-mediated ubiquitylation of CBL or increases CBL ubiquitylation by increasing active ITCH remains unanswered. As multiple WW NEDD4 family members can target different CBL proteins, it is now of great interest to determine the means by which specificity in interactions between the members of these families is achieved in vivo. Non-mutually exclusive possibilities include: differential expression of family members; post-translational modifications that regulate interactions; and spatial juxtaposition. It will also be important to understand the relative roles of selfubiquitylatio n and NEDD4 family-mediated ubiquitylation in the dynamic regulation of CBL levels and how this relates to the oncogenic potential of CBL mutations in different tissues.
Heterologous and self-ubiquitylation at the endoplasmic reticulum. Ubiquitylation at the endoplasmic reticulum (ER) leading to proteasomal degradation is a way of disposing of misfolded proteins and unassembled protein subunits, as well as proteins of the secretory pathway that require tight regulation. ER-associated degradation (ERAD) represents a critical homeostatic and regulatory set of processes. Failure to adequately degrade proteins results in ER stress, which in turn triggers a complex cellula r response known as the unfolded protein response (UPR) (reviewed in REF. 60 ).
gp78 is a pro-metastatic mammalian polytopic ERAD E3 (REF. 61, 62) that targets substrates by means that are not limited to direct interactions. This is because recognition of already ubiquitylated proteins may occur via the ubiquiti n-binding CUE (coupling of ubiquitin conjugation to ER degradation) domain of gp78 (REF. 63 ), or proteins may be targeted through co-localization to micro domains of the ER where the degradation and ER dislocation machinery are concentrated 64 . If the levels of gp78 are too high, critical regulatory proteins, such as insulin-induced gene 1 (INSIG1; a regulator of cholesterol metabolism) and KAI1 (also known as CD82; a metastasis suppressor), may be inappropriately degraded 62, 65 . Presumably as a means to avoid such targeting, gp78 self-ubiquitylates, leading to proteasomal degradation in a manner that is dependen t on its RING finger, its CUE domain and its unusual binding site for its cognate E2 (UBE2G2 (also known as UBC7)), known as the UBE2G2-binding region (G2BR), which allosterically activates gp78 by increasing the affinity of UBE2G2 for gp78 (FIG. 3b) . This leads to both enhanced self-ubiquitylation and degradation of substrates 66, 67 . Other mammalian and yeast ERAD E3s have also been shown to undergo self-ubiquitylation (TABLE 1) .
In addition to targeting itself for degradation, gp78 is also targeted for ubiquitylation and proteasomal degradation by another mammalian polytopic ERAD E3, HMG-CoA reductase degradation protein 1 (HRD1; also known as synoviolin (SYVN or SYNO)) 68, 69 . This targeting is unidirectional (FIG. 3b) and, unlike the selfubiquitylatio n of gp78, is independent of the ligase activity of gp78. Importantly, the targeting of gp78 for degradation is not just a function of manipulation of HRD1 levels in tissue culture, as gp78 in mouse embryonic fibroblasts (MEFs) from Syvn -/-mice is stabilized 68 . Interestingly, coimmunoprecipitation of gp78 with HRD1 is abrogated by mutation of the gp78 CUE domain 69 , which binds ubiquitin 66 . Whether this CUE domain-mediated interaction contributes to gp78 being targeted for degradation by HRD1 or simply reflects loss of the intermolecular 'glue' provided by domains such as CUE that bind ubiquitin chains is unknown. The significance of this targeting is underscored by the finding that the alteration of gp78 levels by HRD1 affects gp78 substrates but not those of HRD1 (REF. 68 ).
Unlike gp78, endogenous HRD1 is a relatively stable protein. Studies on its similarly stable yeast counterpart Hrd1 (also known as Der3) 70 , which has a critical role in targeting HMG-CoA reductase and thereby regulating sterol synthesis, have led to important insights into the determinants of stability for Hrd1. In particular, the stability of this yeast RING finger E3 was found to be dependen t on its stoichiometric relationship with its polytopic binding partner Hrd3, with loss of Hrd3 leading to Hrd1 degradation 70 ; recently a similar role has been shown for suppressor of LIN-12-like 1 (SEL1L), which is a mammalian orthologue of Hrd3 (REF. 71 ). The degradation of Hrd1 is dependent on a third transmembrane component of the Hrd1 ligase complex U1 SNP-associating 1 (Usa1) 72 , which is necessary for its normal function in ERAD 72, 73 . Usa1 serves as part of the scaffold for oligomerization of the Hrd1 complex 73 . Usa1, and particularly its N-terminal ubiquitin-like domain, is required for the self-ubiquitylation and proteasomal degradation of Hrd1 (REF. 72 ). Furthermore, consistent with a role in oligomerization, this Usa1-dependent self-ubiquitylation of Hrd1 occurs in trans (that is, one Hrd1 molecule ubiquitylates another) 72 . Thus, these yeast genetic studies illustrate two important concepts: first, that other interacting molecules can play a critical part in the self-ubiquitylation of ligases leading to degradation (see also the apoptosis section below), and second, that self-ubiquitylation can clearly occur between two molecules of the same ligase.
Heterologous and self-ubiquitylation in gene regulatio n. E3s can both self-ubiquitylate and be ubiquitylated by heterologous ligases, and the self-ubiquitylation can have functions other than targeting the ligases for proteasomal degradation. One such example is the RING finger 1B (RING1B; also known as RNF2) component of polycomb repressive complex 1 (PRC1), which selfubiquitylates to increase its activity. The polycomb group (PcG) complex regulates repression of transcription during D. melanogaster development via post-translational modifications of nucleosomal histones. There are two PRCs, PRC1 and PRC2. The human PRC1 contains, among other proteins, two RING finger-containing proteins, RING1B and B lymphoma Mo-MLV insertion 1 (BMI1). PRC2 contains enhancer of zeste homologue 2 (EZH2), which is a histone methyltransferase. The concerted histone-modifying activities of the two complexes silence gene expression. Initially, PRC2 methylates Lys27 on histone H3 (H3K27), leading to the recruitment of PRC1 (REF. 74 ). Following binding to methylated H3K27, RING1B catalyses monoubiquitylation of histone H2A on Lys119. Like MDMX, BMI1 lacks intrinsic E3 activity; however, when it dimerizes with RING1B through their RING fingers, it enhances the ligase activity of RING1B towards histone H2A 75 . As well as catalysing the ubiquitylation of histone H2A, RING1B mediates its own polyubiquitylation. However, the self-ubiquitylation does not target RING1B for degradation, as a mutation in the RING finger that abolishes self-ubiquitylation does not affect its proteasomal degradation 75 . It seems that the self-generated ubiquitin chains do not target RING1B for degradation because, rather than forming canonical homogenous Lys48 or other proteasome-targeting polyubiquitin chains, RING1B generates atypical, mixed and multiply branched (or 'forked'; in which one ubiquitin moiety can be modified by several ubiquitin molecules anchored to different Lys residues) Lys6-, Lys27-and Lys48-linked polyubiquitin chains 75 . The forked chains are probably not degraded by the proteasome 76 . Strikingly, this unique modification stimulates the RING1B histone H2A monoubiquityl ating activity, thus providing a novel mechanism for ligase activation through this 'non-canonical' self-ubiquitylation. This finding raised the hypothesis that RING1B must be targeted for degradation by a heterologous ligase. E6-associated protein (E6AP; also known as UBE3A) was identified as one ligase that can target RING1B 77 . It generates Lys48-linked chains on RING1B, which targets the protein for degradation 77 . The self-ubiquitylation of RING1B and the modification by E6AP both tag the same Lys residues on RING1B, suggesting a high level of regulation of activation versus degradation of RING1B. Both types of chains are disassembled by USP7, which stabilizes RING1B and resets its activity (the regulation of RING1B by ubiquitylation is depicted in FIG. 4a) . The elevated levels of RING1B and ubiquitylated H2A observed in Purkinje neurons (and other tissues) from E6AP-deficient mice 77 could have a role in aberrant transcriptional repression. This may have implications for the pathogenesis of Angelman syndrome, a neurodevelopmental disorder caused by E6AP deficiency.
Heterologous and self-ubiquitylation in apoptosis. The UPS has major mechanistic roles in regulating apoptosis (reviewed in REFS 78, 79) . Critical regulatory proteins involved in cell death pathways are modified and degraded by the ubiquitin system. These include, for example, the pro-survival protein myeloid leukaemia cell differentiation 1 (MCL1) and the pro-apoptotic proteins BH antagonist or killer (BAK) and BAX. Key proteins involved in related pathways are also regulated by the UPS and include, among others, p53, cell cycle regulators, components of DNA damage response pathways and transcription factors, such as NF-κB. Inhibitor of apoptosis proteins (IAPs), which are critical negative regulators of cell death, are RING finger E3 ubiquitin ligases 80 . Among these are X chromosome-linked IAP (XIAP), cell ular IAP1 (cIAP1; also known as BIRC3) and cIAP2 (also known as BIRC2), which suppress cell death by inactivatin g pro-apoptotic regulators, such as caspases. As regulation of IAPs has important roles in regulating cell death (and survival), it is not surprising that they are regulated by several mechanisms, including self-ubiquitylatio n to regulate ligase degradation and activity, as well as regulation by heterologous ligases [81] [82] [83] . Thus, following an apoptotic stimulus, the pro-apoptotic protein Reaper -and possibly also head involution defective (HID; also known as Wrinkled) and Grim, which are members of the RHG family of proteins -induces accelerated self-ubiquitylation and rapid degradation of D. melanogaster IAP1). Reaper binds D. melanogaster IAP1 via a short IAP-binding motif (IBM) at its N-terminus, a binding that probably facilitates the transfer of a ubiquitin moiety from the E2 to the ligase 82 (reviewed in REF. 84 ). By contrast, the basal self-ubiquitylation catalysed by the enzyme in the absence of Reaper appears to generate non-canonical Lys63-linked chains that do not target the ligase for degrad ation but rather decrease its activity towards hetero logous substrates, such as NEDD2-like caspase (NC; also known as DRONC) 83 .
This suggests yet another novel role for self-ubiquitylation in attenuating ligase activity, which may occur under basal conditions (the regulation of D. melanogaster IAP1 is depicted in FIG. 4b) . Under basal conditions in D. melanogaster, it appears that IAP2 ubiquitylates IAP1, targeting it for degradation 83 . Similarly to D. melanogaster IAP2, Morgue, which has an F box domain and an E2-like domain that lacks the active site Cys, also targets IAP1 for degradation, probably acting as an SCF E3 (REF. 85 ). In mammalian cells, cIAP1 and XIAP are specifically ubiquitylated and degraded following the induction of apoptosis in thymocytes by glucocorticoids or etoposide. The IAPs catalyse their own ubiquitylation, which requires their RING domain. The self-ubiquitylation and degradation of IAPs may be a key event in the apoptotic program 80 . Similarly to the D. melanogaster RHG family members, in mammalian cells SMAC3, and possibly also second mitochondriaderived activator of caspase (SMAC; also known as DIABLO) and apoptosis-related protein in the TGFβ signalling pathway (ARTS), stimulates the autoubiquitylating Step 1: selfubiquitylation of RING1B generates 'non-canonical' mixed (Lys6-, Lys27-and Lys48-based) and multiply branched polyubiquitin chains that stimulate the monoubiquitylating activity of the ligase towards histone H2A but do not target it for degradation.
Step 2: the HECT ubiquitin-protein ligase (E3) E6-associated protein (E6AP), and possibly an additional ligase, targets RING1B for proteasomal degradation by generating Lys48-based polyubiquitin chains. Both the self-and the E6AP-catalysed ubiquitylations target the same Lys residues on RING1B, thus preventing opposing and wasteful activities; that is, the destruction of an active and needed enzyme or the untoward activation of an unneeded enzyme.
Step 3: ubiquitin-specific protease 7 (USP7) deubiquitylates both the activating and the proteasome-targeting polyubiquitin chains. This activity releases free RING1B, thus enabling inactivation and, at the same time, stabilization of RING1B without destroying it. b | Regulation of Drosophila melanogaster inhibitor of apoptosis protein 1 (IAP1) by ubiquitylation.
Step 1: self-ubiquitylation of D. melanogaster IAP1 generates Lys63-based polyubiquitin chains that attenuate the ligase's activity towards its substrates, such as caspases.
Step 2: D. melanogaster IAP2 targets IAP1 for proteasomal degradation by generating Lys48-based polyubiquitin chains on IAP1.
Step 3: following an apoptotic stimulus, Reaper, Head involution defective (HID) and, possibly, Grim (which are known as the RHG family) induce accelerated self-ubiquitylation of IAP1, generating Lys48-based chains that target the protein for degradation.
Step 4: Morgue generates Lys48-based chains either independently or in conjunction with the RHG family members. These chains target D. melanogaster IAP1 for proteasomal degradation. c | In mammals, both cellular IAP1 (cIAP1) and X chromosome-linked IAP (XIAP) can catalyse their self-ubiquitylation, generating Lys48-based chains that probably target them for proteasomal degradation. It is not known whether, like D. melanogaster IAP1, they can also generate non-Lys48-based chains that serve non-proteolytic functions. Intact cIAP1 (or its RING finger domain alone) was shown to catalyse the formation of Lys48-based chains on XIAP1 that target it for degradation. It is not known whether XIAP and/or another ligase can catalyse a similar reaction targeting cIAP1 for degradation. The ligase seven in absentia homologue 1 (SIAH1) can mediate the generation of Lys48-based chains that target XIAP for degradation. This reaction is mediated by apoptosis-related protein in the TGFβ signalling pathway (ARTS), which probably allows for the association of SIAH1 and XIAP. Similarly to the RHG family members, SMAC3 (and possibly second mitochondria-derived activator of caspase (SMAC; also known as DIABLO) and ARTS) can induce accelerated auto-ubiquitylation of XIAP, which leads to its degradation. Solid arrows mark experimentally established ubiquitylations, dotted arrows denote putative ubiquitylations. Ubiquitin-conjugating enzymes (E2s) are not represented graphically in this figure to reduce complexity, but these should be assumed to be involved in all ubiquitylation reactions. E1, ubiquitin-activating enzyme; Ub, ubiquitin.
Microautophagy
The formation of vacuoles containing a small portion of the cytosol that is digested by the lysosomal enzymes following the destruction or dissolution of the surrounding membrane. The process occurs under basal metabolic conditions and, unlike stressinduced macroautophagy, the vacuoles are small and their generation does not involve the formation of a new membrane and the engulfment and digestion of membrane-limited organelles.
activity, leading to accelerated degradation of XIAP following apoptotic stimuli 86 . However, unlike the RHG family member proteins, the mammalian proteins are mitochondrial and exit the mitochondria in response to the apoptotic stimulus. Also, unlike with D. melanogaster IAP1, it is not known whether self-ubiquitylation of mammalian IAPs can lead to the synthesis of non-canonical chains that serve non-proteolytic functions.
Because of the need for tight regulation, IAPs are also controlled by heterologous ubiquitylation. For example, XIAP1 is regulated by cIAP1 (REF. 87 ) (for the regulation of cIAP1 and XIAP, see also FIG. 4c) . The targeting of IAPs by one another in D. melanogaster and mammalian cells appears to establish regulatory loops within apoptotic pathways that fine-tune survival and death signals. XIAP is also targeted for ubiquitylation by the E3 seven in absentia homologue 1 (SIAH1), a reaction that also appears to be mediated by ARTS, which binds to both proteins and appears therefore to facilitate efficient ubiquitylation 88 .
The 26S proteasome
The highly abundant ~2 MDa 26S proteasome is the proteolytic arm of the UPS. It is made of two subcomplexes, the 19S RP and the 20S CP, and in many cases two RPs cap either end of a CP. The CP is made of two β-rings that contain the catalytic sites, each of which is made of seven subunits (β 1-7 ), flanked on both sides by two α-rings, which are also made of seven subunits each. Thus, the structure of the 20S CP is α 1-7 β 1-7 β 1-7 α 1-7 . The RP includes a base and a lid. The base is composed of a hexameric ring of ATPases that function to unfold the substrate and open the gate of the interlacing N-terminal segments of the α-subunits, thus allowing entry of the unfolded substrate into the catalytic chamber. The lid is involved mostly in specific recognition of the ubiquitin signal (reviewed in REF. 89 ) (for the structure of the 26S complex, see FIG. 5a ). Because of its complex structure, numerous targets and need for rapid adaptation to various pathophysiological conditions, this multi-catalytic enzyme complex is stable and not regulated by degradation. Rather, it is primarily regulated by compositional variation.
Some of the integral 20S proteolytic subunits can be replaced in an inducible and tissue-specific manner that alters proteolytic specificities and adapts it to changing needs, most notably immune challenges. In addition to the 19S cap, other proteins and complexes, such as proteasome activator 28 (PA28), bind to the end of the 20S cylinder and activate it by opening the gate. Furthermore, proteasome-associated DUBs and E3s can remodel substrate-anchored polyubiquitin chains, which may modulate their susceptibility for degradation. Other proteins, such as the chaperone ECM29, stabilize the association between different subcomplexes of the 26S proteasome (reviewed in REF. 89 ). Consistent with its longevity, the proteasome appears to be degraded by the lysosome, probably through microautophagy 90 . Recent studies reported the specific ubiquitylation of distinct subunits of the proteasome; however, these modifications seem to serve non-proteolytic functions. Monoubiquitylation of RPN10 regulates the ability of this subunit to bind substrates by sterically inhibiting its ubiquitin-interacting motif (UIM) 91 . Ubiquitylation by the RING finger E3 NOT4 is essential for the integrity and function of the 26S proteasome, probably by affecting the function of ECM29, such that, in the absence of the ligase, ECM29 is ubiquitylated and degraded. A ubiquitylation target (or targets) of NOT4 has not been identified; thus, the underlying mechanism of its action is unknown 92 . It is possible that NOT4 targets the ECM29 ligase and, in the absence of NOT4, the ligase targets ECM29. Cyclindependent kinase regulatory subunit 1 (CKS1) plays a part in transcriptional activation that is independent from its role in regulating the cell cycle 93 . This requires the CKS1 ubiquitin-binding domain, which allows it to bind to the proteasome via its ubiquitylated subunits. CKS1 can probably bind to other ubiquitylated complexes, thus displaying a broad array of transcription-regulating activities.
Several studies suggest that the selective degradation of critical components of the 26S proteasome, or the induced dissociation of its subcomplexes, is involved in the regulation of its activity. Treatment of hippocampal neurons with the neurotransmitter NMDA (N-methyl-daspartate) leads to dissociation of the 26S to the 19S cap and the 20S core and to proteasomal degradation of the 19S 94 . The mechanism that underlies the effect of NMDA is not known. It is possible that, as there is also a decrease in ubiquitin conjugates following NMDA treatment (see below), the effect on the proteasome is indirect, and proteasome levels decrease when there are fewer substrates to degrade. Interestingly, it was reported that binding of polyubiquitylated substrates to the 19S RP activates proteasomal activity. This probably occurs by inducing conformational changes in the 20S CP that stabilize the gate opening of the α-subunits and thereby facilitate channelling of substrates into the 20S and their access to its active sites. Although it has not been shown experimentally, this crosstalk between the 19S RP and 20S CP, and the stabilization of the protrusion of the N termini of the α-subunits into the 19S RP, may contribute to the strengthening and stabilization of the association between the two subcomplexes 95, 96 . Also, as the proteasome is involved in the endocytosis of glutamate receptor (for which NMDA is a ligand), the effect of NMDA on the proteasome may serve to potentiate the excitatory influence of the transmitter by inhibiting receptor endocytosis and subsequent degradation. It is assumed that the 19S dissociates into individual subunits before its degradation, although evidence for their ubiquitylation is lacking. Along with the 19S, two of its associated E3s, E6AP and HUWE1 (HECT, UBA and WWE domain-containing 1), are also degraded in response to NMDA 94 . It is possible that the destruction of the proteasome-associated ligases suppresses conjugation and degradation and stabilizes a subset of proteins required for synaptic activity during NMDA excitation.
In another study, it was reported that the activation of apoptosis results in caspase-mediated cleavage of the proteasomal subunits RPT5 (also known as 26S protease regulatory subunit 6A), RPN10 (also known as 26S proteasome regulatory subunit S5A), and RPN1 (also known as 26S proteasome non-ATPase regulatory sub unit 2), resulting in proteasome inactivation 97 . As a result, pro-apoptotic proteins, such as SMAC, that are targeted by the UPS are stabilized, which is assumed to facilitate the execution of the apoptotic program. Interestingly, in myotubes, caspase 3-mediated cleavage of RPT2 and RPT6 increases proteasomal activity. This appears to be a specific feedforward mechanism that accelerates proteol ysis in muscle cells during catabolic states 98 . Oxidative stress has been shown to induce the disassembly of the proteasome to its subcomplexes 99 . It was suggested that this dissociation protects cells by enabling the released 20S CP to degrade the oxidized proteins that are gener ated under these conditions, bypassing the need for ubiquitylation, as the 20S can degrade proteins in a ubiquitin-independent manner in vitro. However, it is unclear whether the 20S can degrade cellular substrates in vivo, as several strong lines of evidence suggest that even unfolded, oxidized and otherwise damaged proteins are degraded in the cell via a ubiquitin-dependent mechanism. Thus, in one study it was demonstrated that degradation of damaged cellular proteins exposed to heat, cadmium or paraquat required the E2s Ubc4 and Ubc5, the proteasomal subunit Rpn10 and the Cdc48-Ufd1-Npl4 complex 100 . Also, the absolute requirement for ATP for all types of protein degradation suggests a need for ubiquitylation, which is ATP-dependent, and/or for the 26S complex, which requires ATP for its assembly and function. By contrast, degradation by the 20S CP is energy-independent. An independent study that supports the notion that the 20S proteasome is inactive in cells was described in yeast, in which, during the stationary phase, the 26S proteasome similarly dissociates 101 . In this case, the released 20S is inactive, as the N termini of the α-chains at either end of the CP remain interlaced, thus the entry gate to the CP is closed. This study suggests that dissociation is essential to slow proteolysis and maintain viability during nutrient shortage in the stationary phase. Regulation of the 26S proteasome by association-dissociation of its subcomplexes and degradation of its different subunits is described in FIG. 5b. Perspective Ubiquitin, ubiquitin-conjugating proteins and ubiquitinprotein ligases are not exempt from the powerful regulation of protein fate and function that is conferred by the UPS, and it is likely that individual proteasome components are also targeted. DUBs are also targeted for ubiquitylation, although here the role of ubiquitylation appears to generally not result in proteasomal degradation.
In considering the degradation of ubiquitin, a number of critical questions remain. Perhaps foremost among these is, why is ubiquitin degraded? In many ways, one can view this polypeptide as a reversible modifier that should not be consumed as part of the major process that it facilitates -proteasomal degradation. Yet, it is degraded. Is it simply degraded as bystander or Figure 5 | The 26S proteasome and its regulation by degradation. a | Structure of the 26S proteasome. The 26S proteasome comprises two subcomplexes -the core 20S catalytic particle (CP) and the 19S regulatory particle (RP). The substrate is first bound, probably via its polyubiquitin chain (or chains), to specific subunits in the 19S RP. It is then probably unfolded by ATPases residing in the base of the RP (the RPT ring) and inserted via an open gate in the α-ring of the 20S CP into the proteolytic chamber. The ATPases are probably also involved in opening the interlacing chains that close the gate into the α-ring of the CP, thus allowing entry of the unfolded substrate. The RP also contains deubiquitylating enzymes that recycle ubiquitin and/or edit the polyubiquitin chain to enhance substrate binding to the RP and recycle ubiquitin. An RP-associated ubiquitin ligase (or ligases) may also function to adapt the chain length and/or type for optimal recognition by the RP and recycle ubiqitin. Proteolysis of the substrate is mediated by three pairs of proteolytically active β-subunits inside the proteolytic chamber, which includes two adjacent β-rings. b | Regulation of the assembly and disassembly of the 26S proteasome, and the degradation of its subunits. The entire proteasome or its subcomplexes are probably degraded by the lysosome via microautophagy. Different factors control the assembly of the proteasome (for example, ATP, ECM29, proteasome inhibitors and ubiquitylated substrates) and the disassembly of the proteasome to its RP and CP (for example, NMDA (N-methyl-d-aspartate) and different stresses, such as oxidative stress and starvation). The RP can be further disassembled into its individual subunits, which are probably degraded by proteasomes following ubiquitylation. For further reading on the structure and function of the proteasome, see REF. 89. is its degradation integral to the mechanism by which ubiquitylated substrates are fed to the 26S proteasome? Beyond this, although we know free cellular ubiquitin levels vary with different conditions, we have little insight into how degrading ubiquitin might play a part in cell ular homeostasis or might benefit the organism during development, stress and in other settings.
The regulation of E2 and E3s by ubiquitin is a fascinating area, in which we are clearly just beginning to scratch the surface. We now understand that the selfubiquitylatio n that is stimulated in the test tube is more often a reflection of what can occur in vivo than we may have originally perceived. But what cellular factor s determine whether any particular E3 will target itself or another E3 for ubiquitylation? And among the types of ubiquitin modifications that can occur through this process, what determines the type of linkage generated and thus the fate of the protein? Although E3s can clearly target one another, among the examples discussed herein (NEDD4-CBL, HRD1-gp78, E6AP-RING1B, cIAP1-XIAP1 and D. melanogaster IAP2-IAP1), this apparently occurs in a unidirectional manner. Why this vectorial ubiquitylation occurs is not intuitively obviou s as, in many cases, ubiquitylation occurs as a result of juxtaposition of the ligase and any of a number of different Lys residues or other acceptors on a substrate, either naturally or through artificial targeting. One possible explanation is that acceptor residues are somehow exposed on one ligase and not the other when the two associate, although there are certainly a number of other possibilities. Regardless of the means of association, the basis for these particular asymmetrical relationships between E3s represents new physiological and mechanistic questions to add to the unanswered questions about the functions and mechanics of ubiquitylation.
Finally, and related to the previous point, there exist multiple examples of kinase cascades. In the examples cited herein, we deal at the most with two ligases. We should consider the possibility that, within the dense cellular milieu, linear or pyramidal cascades of ubiquitylation of E2s and E3s are taking place (FIG. 2B) . These probably include bidirectional ubiquityl ation of ligases with the dynamics of ubiquitylation regulated in part by specific DUBs. As with the ubiquitin system in general, should such cascades exist, they are, in all probability, exquisitely regulated in a temporal and spatial manner.
